Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
But now that it has been written we will see the 1,000,000 figure used!
A CIDE is not a cancer drug! Viruses are different. Way less time to see a reaction or lack of it. This cuts out a lot of the trial times. Viruses generally have a 14 day cycle, so results can be seem quickly. and Blood tests with a scope can see if the blood has cleared of the virus.
you bought into the ihub method, post a twist, repost some thing to confirm the twist, write about the twist as if it came from on high, and post that it is a lie.
There is no creditable basis for assuming the results were not current.
People can change their mind. When you as good at what he does and work at what you love you don't flip a switch and walk away! I bet he didn't "turn in his keys".
As I said the link to their sight has his pics and a copyright symbol with a 2015 date after it.
Go buy some NNVC today before you lose you shirt.
This link has a copyright date of 2015.
He looks like a healthy man.
http://www.neomed.edu/academics/medicine/departments/integrative-medical-sciences/faculty-research-laboratories/kenneth-s.-rosenthal-lab
Why would you try to disparage him?
Could one of us request the data via the freedom of information act?
Why speculate? Ask the good doc and you will receive an answer!
Altho we do not have any news from the Army, we do not have any bad news which would NEED TO BE pr immediately.
What type of work schedule are you thinking NNVC will be using?
Plant opens for work at 8 am. Close the doors at 5 pm,?
OR
with all the new hires plant run 24/7. Shifts over lap to ensure quality control. Week ends are work days! NNVCis in the business of saving lives and healing very sick people. The sickest are hospitalized 24/7 until death or recovery! Why shouldn't the hiring interviews look for PHDs willing to use their skills to achieve the end point faster. There will be plenty of work when the Flucide has demonstrated the backbone works in Humans. NNVC has show it works in 6,000+ animals. Full speed ahead, damn the torpedoes (FDA) .
you are absolutely right. I hate to be tarred with others sins. cides are different than creams, or treatments.
You summarily dismiss all the testing that INDEPDANT labs have done and REPORTED. 6000+ animals and counting. cures and no TOXICITY to date.
Gee, I know this new math has come before my time. The complaints about using stock at any rate or discount will have a value of X. Algebra 1 students are confused at first as to what X stands for. So we are going to say X sands for the shares they own and Y is the stock that they will get in interest on X. So they will own X+Y each time a payment comes due. Now we know they have not sold any so lets assign z as to what X+Y=s.
Now some are forcasting NNVC will go to ZERO$$$s.
What value will z times zero$$s =? Maybe I am wrong, but anything times zero = 0.
Why complain. They are receiving 0 and will lose what ever they have put up!!
Or is the old math wrong?
This was missed due to the EB2 craze.
http://www.nanoviricides.com/companynews.html
Non Toxic
Leif, with software, as we made it easier to use we just found bigger idiots to use it!
With biotech the FDA just finds ways to make it so the sickest person can die while they protect the healthiest.
Dr. KAZ, I BELIEVE they are already there with Flucide. The humanitarian decision to help with the Ebola outbreak was immense as it took guts and a lot of fortitude to make such a decision. NO biotech company did anything to stop the spread of Ebola. It may be the same as many of the other viruses in circulation, there is no CURE! so avoid getting it and if you do treat it aggressively with common sense, i.e. drink lots of water, bed rest, and don't share it.
Now let's get Flucide going so we can have the cash to develop no virus cures! IMHO
tHANK you admitting that TOX has started! It can not be stalled unless it has started!
What I wish for is the Army giving us the results and one of the countries in Africa asking us to help them!
Since I am the one responsible for the
"NO NEWS...." SAYING
when we get any news it resets. But, I agree the longer we wait the more the pressure builds.
But on the good side every day without bad news is good news as bad news must be PR immediately.
What to do? What to support? With Ebola being contained (yes, contained, not cured) Does NNVC move on to our cash cow, FLU?
Could we divert the backbone to the table with the Flu ligands and be in the same place as before? If china ask us to give them a batch.....
And on a IMHO thought. Will the clinical trial of Tekmira’s non-vaccine Ebola therapy sicken some who would not be harmed without the "shot or dose? How long will it be before results can be seen?
BIG decisions for our Drs.
WITH 30 MIN TO GO it appears to me from the trading charts and trade flows that.
Volume is still very light.
And, investors are not rushing to sell at these prices.
So many fronts that can and will cause a spike.
UW expert on Ebola outbreak: 'Not just a one-off event'
U.S. drug-development process must be accelerated, Katze says
By Michael McCarthy | HSNewsBeat | Updated 10:00 AM, 08.25.2014
Posted in: Healthcare
Colorized transmission electron micrograph (TEM) revealing some of the ultrastructural morphology displayed by an Ebola virus virion. Cynthia Goldsmith, CDC
While the Ebola outbreak in West Africa has captured the world’s attention, it’s important to bear in mind that Ebola is just one of many emerging infections that we must confront in the coming years, said Michael Katze, a professor of microbiology at the University of Washington. He and his team study Ebola at a high-level biocontainment facility at the Rocky Mountain Laboratories in Hamilton, Mont.
“Ebola is not the only emerging virus; it’s just the most famous one,” Katze said. “There’s West Nile, which was never in North America before and now is everywhere. There’s Chikungunya virus, which had never been in the Americas but now has spread through the Caribbean and has reached the southern United States. There’s SARS (Severe acute respiratory syndrome), which spread from Asia to Toronto and Vancouver, and there’s MERS (Middle Eastern Respiratory Syndrome) that still ongoing in Saudi Arabia and the Middle East. That epidemic isn’t over. The camels in Saudi Arabia are still spreading MERS. It’s just that it’s not on the front pages anymore.
'A lot of emerging infections don’t have the star power. Ebola has star power. But these are all bad actors.”
Michael Katze's microbiology lab at UW aims to define virus-host interactions and the strategies that viruses use to evade cellular defense mechanisms.
Ebola's rock-star status stems in large part from Richard Preston’s best-selling 1994 book, “Hot Zone,” which focused on an Ebola outbreak, Katze said. “The book gave a tremendous boost to virology. There are kids in this laboratory who went to graduate school because they read 'Hot Zone' in eighth grade.”
Despite its reputation, Ebola is neither the scariest virus, Katze said, nor the deadliest. While it has killed more than 1,000 people during this outbreak, seasonal flu kills 30,000 Americans, on average, every year. And Ebola's 90% mortality rate is outpaced by rabies, which without treatment is fatal in every case.
Unlike influenza, which can be spread through the air, it appears direct contact with fluids from an infected person is required in order to contract Ebola, limiting its ability to spread through a community, Katze said.
“There will most likely be no Ebola epidemic in the United States. Bringing the two missionaries here from Africa poses almost zero risk, because we know they are infected and they are going to be quarantined.
“But that’s not the case with the traveler who gets on a flight from Liberia with no symptoms and then lands in Lagos sick. Lagos is a problem: There are 20 million people and it's crowded. In small communities, because the virus kills so quickly, Ebola tends to burn out. But we don’t know what will happen if this virus begins to spread in a city the size of Lagos.”
The U.S. Food and Drug Administration and Centers for Disease Control and Prevention’s standard procedures are too slow and cumbersome to respond to Ebola and other emerging pathogens, said Katze, who seeks accelerated development of new drugs and vaccines.
“We have an Ebola vaccine that’s 100% effective in nonhuman primates, and it has been given to people whose spouses were infected with Ebola and to laboratory workers who have stuck themselves with Ebola. We don’t know whether it was due to the vaccine, but they didn’t get Ebola. We also have monoclonal antibody drugs. We know antibody treatments work. These drugs should be tested quickly.”
He cited other factors, too: Deforestation puts people into contact with new pathogens, and climate change extends the range of mosquitos and other disease carriers. A disease once isolated in a remote village can travel the globe in hours.
“Ebola will be off the front pages soon, but it will be back,” he said. “People should be aware that this outbreak is not just a one-off event.”
Listen to a UW Medicine Pulse podcast on Ebola.
if news were out there would be a lot more than 792 shares traded at no change.
But, 1. no news is good news.
2. News is overdue in my estimation. so many possible items need to be PRed.
to expand on
______________________
Everyone can have their own opinion about this. FluCide has much stronger preclinical efficacy results than EbolaCide, so I don't think an EbolaCide2 failure (or mixed success as before) will say much about FluCide.
____________________
Without a -4 lab we have no way of experimenting with Ebola, so to make any judgment carries no weight.
On the other hand the Flucide has be shipped out and tested and refined many times. This work has our Docs CERTAIN that they have it nailed.
trying to equate humane treatment in required testing to harming animals is a very disingenuous thing. Also, the cides are agnostic. Do you know what this means?
Tell that to the OVER 6,000 ANIMALS who have been used to test our cides. No Toxicity!!! New plant to make copious amounts in, testing the most high profile virus at USARMY lab now, and for about the last 6 weeks. This is a gem of a buy!
wrong time zone
Top Institutional Holders
Holder
Shares
% Out
Value*
Reported
BlackRock Fund Advisors 1,179,960 2.09 3,209,491 Dec 31, 2014
Vanguard Group, Inc. (The) 1,110,560 1.96 3,020,723 Dec 31, 2014
Northern Trust Corporation 426,716 0.75 1,160,667 Dec 31, 2014
State Street Corporation 420,435 0.74 1,143,583 Dec 31, 2014
BlackRock Institutional Trust Company, N.A. 362,433 0.64 985,817 Dec 31, 2014
Geode Capital Management, LLC 210,570 0.37 572,750 Dec 31, 2014
KCG Holdings, Inc. 201,209 0.36 547,288 Dec 31, 2014
Bridgeway Capital Management, Inc. 197,500 0.35 537,200 Dec 31, 2014
Bank of New York Mellon Corporation 169,622 0.30 461,371 Dec 31, 2014
TIAA-CREF Investment Management, LLC 142,257 0.25 386,939 Dec 31, 2014
Top Mutual Fund Holders
Holder
Shares
% Out
Value*
from yahoo. All these are longs just waiting for some news.
Reported
iShares Russell 2000 ETF 729,753 1.29 1,984,928 Dec 31, 2014
Vanguard Total Stock Market Index Fund 635,591 1.12 1,906,773 Sep 30, 2014
Vanguard Extended Market Index Fund 344,847 0.61 1,034,541 Sep 30, 2014
iShares Russell 2000 Growth ETF 324,139 0.57 881,658 Dec 31, 2014
Spartan Extended Market Index Fund 143,363 0.25 389,947 Dec 31, 2014
College Retirement Equities Fund-Stock Account 120,437 0.21 361,311 Sep 30, 2014
iShares Micro Cap ETF 105,673 0.19 287,430 Dec 31, 2014
Bridgeway Funds Inc-Ultra Small Company Market Fund 100,000 0.18 300,000 Sep 30, 2014
Schwab Capital Trust-Small Cap Index Fund 58,800 0.10 224,028 Oct 31, 2014
AQR Funds-AQR Small Cap Momentum Fd 57,800 0.10 173,400 Sep 30, 2014
[url][/url][tag]insert-text-here[/tag]
With this outbreak in India our valuation of NNVC should change.
EB2 because of the nature of disease requires a BSL-4 lab to test the cide in. So NNVC has not had the virus in hand to conduct lab work on.
The flu strain in India is so similar to what is in the "can" and being tested at BASi. Our docs have --- drum roll please-- 100% confidence in Flucide. It has passed with flying colors the current testing. It is NON toxic in the small animals and ready to move into larger animals. The efficacy results are incredible! 6,000 animals and counting with great results.
Not being able to see the future is life.
IF IF IF NNVC had NOT chosen to pursue EB2 it would have been ready NOW to stop this Indian outbreak.
All in my humble opinion.
The report says $36MM but we need to add in the $15mm for the plant in Sheldon. so $51MM is where we are at now.
[url][/url][tag]insert-text-here[/tag]
JG36, in reply to your saying the company shipped without a request is total BS. They had the material ready and were waiting until the request was made!
I feel that we have not paid attention the fact that the Army told us when to ship EB2 candidates! So they must not be storing them for future use. Answers should come soon.
Goes both ways!
Very astute of you to note that!
The POWER of the message boards!!
Hallelujah.
That is why all the faithful have not sold. We are waiting for this guy to tell us to sell.
It is easy to give a prediction! But show some backbone an explain why you think your way!
I have a keen sense of urgency, saving even one life is worth lots. What can so so secretive about how tests are proceeding. No news is good news, but nothing wrong with a factual description of how the work is progressing. IMHO, what is yours?
Remember in BIOTECH "NO NEWS IS GOOD NEWS". if An adverse occurred it would be reported immediately!
So, no news is....
When you are not in love with the stuff it takes to be our docs. Think of these guys. The word brave has been used here. Our docs are brave in a different way, but brave to keep moving forward despite what the sissys say.
<http://voxvocispublicus.homestead.com/morrow.html>
The viruses do not take holidays off. They keep trying to invade cells to produce more virons. The weather in MD is cold with wind and blowing snow. Since they are the Army they must have tanks to get the techs to work in horrible conditions. The tests must be run and monitored on schedule.
EB2 results should be close to starting the reporting phase.
Go NNVC.
I am in for 101.25
With a fifty page report that is very detailed who has had the time to read and assimilate all this.
So, I do believe that the PPS has not scared away some of the small retail investors.
The Short shares are starting to wince at losing on this trade. With the prospects of the share price increasing just from the repot.
The BIG BOOT from the Army is now close to being dropped. The faithful (I am one) expect a grade of A+ from them. If this happens holly sh.t will be the cry of the day. Every news media that is starved for a good news story will be shouting the Name of NNVC.
No down side to this weeks events, all IMHO. Do you own DD.
This good news. These money managers will cut and run in a heart beat if they see they made a mistake.
So why post this
________________________________________
Found_it: Midtown partners has been in NNVC's pocked for a while:
__________________________
As NNVC was not in their pocket just a company looking to raise capitol.
Why would they issue a strong buy if they felt they were not right before? And are right now?